Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.

Saved in:
Bibliographic Details
Title: Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.
Authors: Mahdavinia M; Department of Internal Medicine, Allergy and Immunology Division, Rush University Medical Center, Chicago, Illinois. Electronic address: Mahboobeh_mahdavinia@rush.edu., Batra PS; Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois., Codispoti C; Department of Internal Medicine, Allergy and Immunology Division, Rush University Medical Center, Chicago, Illinois.
Source: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2019 Sep; Vol. 123 (3), pp. 311-312. Date of Electronic Publication: 2019 Jun 24.
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4436
DOI:10.1016/j.anai.2019.06.012